(selectie van publicaties)
T.E. Middelburg et al. Validation of Quantitative Magnetic Resonance Cholangiopancreatography Metrics in Prediction of Transplant-free Survival in Primary Sclerosing Cholangitis. J Clin Exp Hepatol 2026;16(1):103417.
B. Mol et al. Proctocolectomy with permanent ileostomy is associated with improved transplant-free survival in patients with PSC. Journal of Hepatology Reports 2026; online ahead of print.
B. Mol et al. Epidemiological and economical burden of cholestatic liver disease. Hepatology 2025;82(4):813-833.
U. Beuers et al. The history and future of bile acid therapies. Journal of Hepatology 2025;83(5):1172-1188.
F. Wolters et al. The role of bile salts in itch receptor activation. Biochim Biophys Acta Mol Basis Dis 2025;1871(8):167972.
M.C. van Hooff, R.C. de Veer, et al. Effectiveness and Tolerability of Bezafibrate in Primary Biliary Cholangitis: A Nationwide Real-World Study. The American Journal of Gastroenterology 2025; online ahead of print.
D.C. Trampert, R. Kersten et al. Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection. Journal of Hepatology Reports 2024; 6: 101015.
R. Kersten, D.C. Trampert et al. IgG4-related cholangitis – a mimicker of fibrosing and malignant cholangiopathies. Journal of Hepatology 2023; 79: 1502-23.
R.C. de Veer et al. Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis. American Journal of Gastroenterology 2023;118(7):1196-1203.
T. Herta, R. Kersten et al. Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection. Journal of Hepatology. 2022;76(2):319-331.
L. Hubers, A.R. Schuurman et al. Blue-collar work is a risk factor for developing IgG4-related disease of the biliary tract and pancreas. Journal of Hepatology Reports 2021;3(6):100385.
E. de Vries, R. Bolier et al. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial. Gastroenterology 2021;160(3):734-743.e6.
M.H. Harms et al. Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis. Gut 2020;69(8):1502-1509.
M.H. Harms et al. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. Journal of Hepatology 2019;71(2):357-365.
L. Hubers et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut 2018;67(4):728-735.
